HCW Biologics is trading 5.98% up now at $3.10, with no confirmed company-specific catalyst identified for August 14, 2026.

  • The move follows a 7.00% decline to $2.92 on August 13, 2026.
  • Pre-market coverage reported HCW Biologics up 19.66% at $3.50, also without a confirmed catalyst; its official news page lists May 14, 2026 as the latest release.
  • Broader market indexes were slightly lower, so macro sentiment does not clearly explain the move.